Spruce Biosciences Stock Market Value
| SPRB Stock | USD 0.55 0.02 3.77% |
| Symbol | Spruce |
Spruce Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spruce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share 0.173 | Quarterly Revenue Growth (0.80) | Return On Assets (0.30) | Return On Equity (0.58) |
The market value of Spruce Biosciences is measured differently than its book value, which is the value of Spruce that is recorded on the company's balance sheet. Investors also form their own opinion of Spruce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Spruce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spruce Biosciences' market value can be influenced by many factors that don't directly affect Spruce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spruce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Spruce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spruce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spruce Biosciences.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Spruce Biosciences on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Spruce Biosciences or generate 0.0% return on investment in Spruce Biosciences over 30 days. Spruce Biosciences is related to or competes with Inozyme Pharma, Day One, Terns Pharmaceuticals, Eledon Pharmaceuticals, Hookipa Pharma, X4 Pharmaceuticals, and Acumen Pharmaceuticals. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rar... More
Spruce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spruce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spruce Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.99 | |||
| Information Ratio | 0.0121 | |||
| Maximum Drawdown | 16.41 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 6.25 |
Spruce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spruce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spruce Biosciences' standard deviation. In reality, there are many statistical measures that can use Spruce Biosciences historical prices to predict the future Spruce Biosciences' volatility.| Risk Adjusted Performance | 0.0477 | |||
| Jensen Alpha | 0.0519 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0131 | |||
| Treynor Ratio | 0.1783 |
Spruce Biosciences Backtested Returns
Spruce Biosciences appears to be risky, given 3 months investment horizon. Spruce Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.084, which indicates the firm had a 0.084% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Spruce Biosciences, which you can use to evaluate the volatility of the company. Please review Spruce Biosciences' Semi Deviation of 2.36, coefficient of variation of 1906.75, and Risk Adjusted Performance of 0.0477 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Spruce Biosciences holds a performance score of 6. The entity has a beta of 0.9, which indicates possible diversification benefits within a given portfolio. Spruce Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Spruce Biosciences is expected to follow. Please check Spruce Biosciences' value at risk and the relationship between the expected short fall and price action indicator , to make a quick decision on whether Spruce Biosciences' existing price patterns will revert.
Auto-correlation | 0.12 |
Insignificant predictability
Spruce Biosciences has insignificant predictability. Overlapping area represents the amount of predictability between Spruce Biosciences time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spruce Biosciences price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Spruce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Spruce Biosciences lagged returns against current returns
Autocorrelation, which is Spruce Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Spruce Biosciences' stock expected returns. We can calculate the autocorrelation of Spruce Biosciences returns to help us make a trade decision. For example, suppose you find that Spruce Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Spruce Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Spruce Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Spruce Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Spruce Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Spruce Biosciences Lagged Returns
When evaluating Spruce Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Spruce Biosciences stock have on its future price. Spruce Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Spruce Biosciences autocorrelation shows the relationship between Spruce Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Spruce Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Spruce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Spruce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spruce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Spruce Biosciences Stock:Check out Spruce Biosciences Correlation, Spruce Biosciences Volatility and Spruce Biosciences Alpha and Beta module to complement your research on Spruce Biosciences. For information on how to trade Spruce Stock refer to our How to Trade Spruce Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.